|
Post by agedhippie on Jan 13, 2017 17:06:50 GMT -5
Trump's a business man. I think he fully understands what it takes to get a drug to market, and then the right the company has to make a profit. I think Trump has no idea at all what it takes to bring a drug to market. He is a property developer and I would no more expect him to understand drug development than I would expect Matt to understand large scale property development. Fully understanding a business doesn't happen unless you are in that business.
|
|
|
Post by sluggobear on Jan 13, 2017 17:16:05 GMT -5
Trump's a business man. I think he fully understands what it takes to get a drug to market, and then the right the company has to make a profit. I think Trump has no idea at all what it takes to bring a drug to market. He is a property developer and I would no more expect him to understand drug development than I would expect Matt to understand large scale property development. Fully understanding a business doesn't happen unless you are in that business. I agree, Trump has no idea. He doesn't seem to even care or consider the effects his Tweets have on stocks; unless he's truly corrupt and playing Twitter games with individual SP's.
|
|
|
Post by cjc04 on Jan 13, 2017 17:25:54 GMT -5
Trump's a business man. I think he fully understands what it takes to get a drug to market, and then the right the company has to make a profit. I think Trump has no idea at all what it takes to bring a drug to market. He is a property developer and I would no more expect him to understand drug development than I would expect Matt to understand large scale property development. Fully understanding a business doesn't happen unless you are in that business. I wasn't calling him a scientist. It doesn't take a phd to see the costs involved to create a new drug, and then the right to make your money back. I really have to explain that? Or you think that business concept is over his head because it's not real-estate?
|
|
|
Post by agedhippie on Jan 13, 2017 19:39:17 GMT -5
I think Trump has no idea at all what it takes to bring a drug to market. He is a property developer and I would no more expect him to understand drug development than I would expect Matt to understand large scale property development. Fully understanding a business doesn't happen unless you are in that business. I wasn't calling him a scientist. It doesn't take a phd to see the costs involved to create a new drug, and then the right to make your money back. I really have to explain that? Or you think that business concept is over his head because it's not real-estate? No, I think if I want if you want someone who fully understands a market then they are almost certainly directly involved in it and have been for years. You are not talking about concepts, you are talking about fully understanding what is involved in bringing a drug to market and that is a specialized skill.
|
|
|
Post by mnholdem on Jan 18, 2017 14:28:56 GMT -5
Back on topic. A board member was having trouble posting an email response he received from MannKind's Investor Relations Department. That message was then forwarded to my PM with the request that I post it. Apparently the message is that MannKind would/could qualify for a 6 month extension (re: delisting).
So here is the reply to an inquiry about de-listing:
|
|
|
Post by silentknight on Jan 18, 2017 14:43:39 GMT -5
That's a very cryptic response. MNKD would "qualify" even though there's not a qualification criteria per se to appeal for an extension? Based on that statement, it sounds like MNKD would in fact NOT qualify for the extension. On what grounds would you base your request if the company doesn't meet qualification criteria? I hope they have good lawyers.
"Could be" and "would be" are very different things.
|
|
|
Post by kc on Jan 18, 2017 14:59:50 GMT -5
I don't think it was cryptic. I think it was just answered as openly and I Hassli as you can if you're a public corporation. I had is why most public corporations including this one limit their response to emails and what they can say. The internal employee knew that this would be posted on some board and head to basically stick with The script of what you can and can't say without making a SEC filing release statement
|
|
|
Post by cjm18 on Jan 18, 2017 15:30:28 GMT -5
They will appeal. And may or may not be granted the extension. But they sound hopeful.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 19, 2017 10:29:10 GMT -5
|
|
|
Post by steve on Jan 19, 2017 19:00:14 GMT -5
That's a very cryptic response. MNKD would "qualify" even though there's not a qualification criteria per se to appeal for an extension? Based on that statement, it sounds like MNKD would in fact NOT qualify for the extension. On what grounds would you base your request if the company doesn't meet qualification criteria? I hope they have good lawyers. "Could be" and "would be" are very different things. Doesn't seem cryptic at all. With all the other recent efforts and the fabulous recent new hires the only ones trying to spray black paint on anything good are trolls. This seems to be a non issue. Management is not concerned about cash at all. Neither are the new high caliber hires concerned who have a MUCH better vantage than you.
|
|
|
Post by uvula on Jan 19, 2017 19:22:04 GMT -5
Why do so many people here keep saying that management is not worried about funding? We have NO idea what management is thinking. Management is marching forward because that is what they need to do and it is their only option.
I'm not saying that I think management is worried. I'm saying I don't have a clue (about mnkd and many other things.)
|
|
|
Post by silentknight on Jan 19, 2017 19:24:20 GMT -5
That's a very cryptic response. MNKD would "qualify" even though there's not a qualification criteria per se to appeal for an extension? Based on that statement, it sounds like MNKD would in fact NOT qualify for the extension. On what grounds would you base your request if the company doesn't meet qualification criteria? I hope they have good lawyers. "Could be" and "would be" are very different things. Doesn't seem cryptic at all. With all the other recent efforts and the fabulous recent new hires the only ones trying to spray black paint on anything good are trolls. This seems to be a non issue. Management is not concerned about cash at all. Neither are the new high caliber hires concerned who have a MUCH better vantage than you. Guess we'll see in another two months or so whether or not it's an issue. So far, Matt's prediction that the share price would take care of itself has been dead wrong but perhaps something happens before March that can do it. No trolling intended but your slight is noted. Unnecessary but noted. My point was that the email, if you actually read it, doesn't tell us much besides what we already knew; MNKD could apply for the extension but they probably aren't qualified for it. That has been debated in other threads and discussed in depth in articles. I'm not concerned about cash either. They have enough of that to get them through 2017 pretty easily when you factor in their lines of credit and the ATM. But that's besides the point. Cash has absolutely nothing to do with delisting. Only share price does. As far as the new hires, nobody knows what they're concerned about but I certainly hope they're concerned with selling Afrezza better than we've seen so far. Im confident they are or they wouldn't be there.
|
|
|
Post by gamblerjag on Jan 19, 2017 22:54:52 GMT -5
I'm not seeing anything in this email where it eludes to MNKD may not qualify for the extension
"We have spoken to NASDAQ and understand that a 6 month extension could be granted. MNKD would “qualify”, even though there’s not a qualification criteria per se to appeal for an extension. It is available to any issuer who receives a delisting notice."
|
|
|
Post by agedhippie on Jan 20, 2017 8:40:12 GMT -5
I'm not seeing anything in this email where it eludes to MNKD may not qualify for the extension "We have spoken to NASDAQ and understand that a 6 month extension could be granted. MNKD would “qualify”, even though there’s not a qualification criteria per se to appeal for an extension. It is available to any issuer who receives a delisting notice." In my glass half empty role - the the key words are "extension could be granted", and "there’s not a qualification criteria per se to appeal". In other words anyone can appeal and may or may not get it. It is a non-message but that is to be expected since saying anything else is market moving information and they would have need to issue a release to ensure that everyone is aware of the update if they said more - that is not appropriate for an investor inquiry.
|
|
|
Post by saxcmann on Jan 20, 2017 9:10:03 GMT -5
To me it simply suggests mnkd management thinks they'll get an extension. Like Aged post implies they can't say much more than that...
|
|